Endocrinology
Desoxycorticosterone Pivalate for Dogs With Addison’s Disease
DOCP is a safe and effective mineralocorticoid replacement therapy when used in dogs with primary hypoadrenocorticism.
Menu
DVM, PhD, DACVIM (SAIM), DACVCP
Dr. Fellman is an assistant professor of small animal internal medicine and clinical pharmacology at Cummings School of Veterinary Medicine at Tufts University. She completed her clinical training and earned her PhD degree from Mississippi State University. Her interests include immunology, pharmacology, and antimicrobial stewardship
DOCP is a safe and effective mineralocorticoid replacement therapy when used in dogs with primary hypoadrenocorticism.
This article covers its development, mechanism of action, dosage, safety, and efficacy against 6 common species of ectoparasites.
Stay current with the latest techniques and information – sign up below to start your FREE Today’s Veterinary Practice subscription today.
Start My SubscriptionTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.